CClinicalTrials.gg
Status unknownNCT05399472Updated Jun 7, 2022

Teenage Functional Hallux Limitus and Ankle Dorsiflexion Study

An observational study in Hallux Limitus and Ankle Joint, sponsored by University of Bologna. Status unknown at 1 site in Italy. Open to male participants aged 12 Years to 17 Years. Per ClinicalTrials.gov, last updated 2022-06-07.

Sponsored by University of Bologna · Observational

The sponsor has not verified this record recently (last verified Jun 2022), so the status shown — last known as Enrolling by invitation — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
50
Ages
12 Years to 17 Years
Sex
Male
01

Study summary

This study aims to identify a possible correlation between reduced mobility of the first toe under load and reduced mobility of the ankle ROM in healthy adolescent basketball players. To reach this goal, two non-invasive tests will be performed to measure the amount of movement of the ankle joint and the first toe.

Read the detailed description

Functional hallux limitus (FHL) is a common condition of the first metatarsophalangeal joint (MTF) characterized by reduced dorsiflexion (DF) under load and has a negative effect on load transfer during toe off.

This condition is especially common among athletes, even at a youth age, due to repeated loads that can lead to tissue and/or joint damage. The compensations that occur in athletes with an FHL can negatively affect sports performance and start injuries.

Limited ankle dorsiflexion under load is another element that can affect sports performance as well as predisposing to injury. Several studies have investigated its regional interdependence but only a few have hypothesized a correlation between this limitation and FHL.

The aim of this study is to understand a possible correlation between reduced ankle DF and reduced MTF dorsiflexion during loading, so that preventive action can be taken to reduce the risk of injury.

Participants will fill in a cross-check survey to establish if there are any predisposing factors for FHL or ankle DF reduction.

The dorsiflexion lunge test (DLT) will be used to measure ankle dorsiflexion. The Jack Test will be used to measure first toe dorsiflexion under load and the Dorsiflexion Lunge Test will be used to measure ankle DF.

02

Conditions studied

  • Hallux Limitus
  • Ankle Joint

Keywords

  • Functional hallux limitus
  • Ankle dorsiflexion
03

In context

Hallux Limitus

31 studies on the registry are indexed under Hallux Limitus; 3 are open to participants now.

Browse Hallux Limitus studies →

Lead sponsor

University of Bologna is the lead sponsor of 153 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 17 Years
Sexes eligible
Male
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Male teenager basketball players from Bologna competitive sports clubs.

Inclusion criteria

  • male teenages basketball players enrolled in a competitive sports club
  • teenagers whose parents have signed the privacy and consent forms

Exclusion criteria

Exclusion Criteria:

  • athletes who have suffered in the last 3 months of lower limb musculoskeletal disorders such as pain for more than 7 days (ankle distortion outcomes, leg/foot fractures, plantar fasciopathy, metatarsalgias, etc);
  • athletes who have undergone surgery on their lower limb.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Participant

    The participants must be teenage basketball players (12-17 years old). The exclusion criteria are: * have suffered in the last 3 months of lower limb musculoskeletal disorders such as pain for more than 7 days (ankle distortion outcomes, leg/foot fractures, plantar fasciopathy, metatarsalgias, etc); * athletes who have undergone surgery on their lower limb.

    Diagnostic Test: Dorsiflexion lunge test · Diagnostic Test: Jack Test

Interventions

  • Diagnostic testDorsiflexion lunge test

    The dorsiflexion lunge test (DLT) will be used to measure ankle dorsiflexion. To perform this test, the participant stands in front of a wall holding the foot of their limb to be measured perpendicularly to it. The other foot is to be kept behind it. The participant is asked to perform a lunge (to dorsiflex the ankle and bring the knee into flexion) until the front knee touches the wall without the heel lifting off the ground. The participant steps away from the wall as much as possible as long as the knee keeps touching the wall. Measurement in centimeters is taken from the heel of the examined leg to the wall.

  • Diagnostic testJack Test

    The Jack Test will be used to measure the first toe dorsiflexion under load. The examiner pulled the proximal phalanx of the hallux to dorsiflexion with his hand until the maximal amount of mobility was reached with the subject standing. The static arm of the goniometer was placed along the first metatarsal longitudinal axis while the free movable arm followed the proximal phalanx of the hallux axes.

06

What researchers measure

Primary outcomes

  1. Dorsiflexion Lunge Test

    Measurement in centimeters taken from the heel of the examined leg to the wall.

    Time frame: T1: first day

  2. Jack test

    Degrees of movement will be measured with a goniometer. Static arm of the goniometer was placed along the first metatarsal longitudinal axis while the free movable arm followed the proximal phalanx of the hallux axes.

    Time frame: T1: first day

07

Study locations

1 site
  • Dipartimento di scienze biomediche e Neuromotorie (DIBINEM) - Università di Bologna (MED/48)
    Bologna, 40130, Italy
08

References and documents

Publications

  • Payne C, Chuter V, Miller K. Sensitivity and specificity of the functional hallux limitus test to predict foot function. J Am Podiatr Med Assoc. 2002 May;92(5):269-71. doi: 10.7547/87507315-92-5-269. PubMed 12015407 ↗
  • Van Gheluwe B, Dananberg HJ, Hagman F, Vanstaen K. Effects of hallux limitus on plantar foot pressure and foot kinematics during walking. J Am Podiatr Med Assoc. 2006 Sep-Oct;96(5):428-36. doi: 10.7547/0960428. PubMed 16988174 ↗
  • Lafuente G, Munuera PV, Dominguez G, Reina M, Lafuente B. Hallux limitus and its relationship with the internal rotational pattern of the lower limb. J Am Podiatr Med Assoc. 2011 Nov-Dec;101(6):467-74. doi: 10.7547/1010467. PubMed 22106194 ↗
  • Durrant B, Chockalingam N. Functional hallux limitus: a review. J Am Podiatr Med Assoc. 2009 May-Jun;99(3):236-43. doi: 10.7547/0980236. PubMed 19448175 ↗
  • Aranda Y, Munuera PV. Plantar fasciitis and its relationship with hallux limitus. J Am Podiatr Med Assoc. 2014 May;104(3):263-8. doi: 10.7547/0003-0538-104.3.263. PubMed 24901585 ↗
  • Sanchez-Gomez R, Becerro-de-Bengoa-Vallejo R, Losa-Iglesias ME, Calvo-Lobo C, Navarro-Flores E, Palomo-Lopez P, Romero-Morales C, Lopez-Lopez D. Reliability Study of Diagnostic Tests for Functional Hallux Limitus. Foot Ankle Int. 2020 Apr;41(4):457-462. doi: 10.1177/1071100719901116. Epub 2020 Jan 29. PubMed 31994419 ↗
  • Tregouet P. An assessment of hallux limitus in university basketball players compared with noncompetitive individuals. J Am Podiatr Med Assoc. 2014 Sep-Oct;104(5):468-72. doi: 10.7547/0003-0538-104.5.468. PubMed 25275734 ↗
  • Hall C, Nester CJ. Sagittal plane compensations for artificially induced limitation of the first metatarsophalangeal joint: a preliminary study. J Am Podiatr Med Assoc. 2004 May-Jun;94(3):269-74. doi: 10.7547/0940269. PubMed 15153589 ↗

Individual participant data

Plan to share: Undecided — IPD will be sharing by a publication and will be stored and shared with those who request it while maintaining the anonymity of participants.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 7, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05399472
Lead sponsor
University of Bologna
Responsible party
Ballardin Francesco (Clinical Professor, University of Bologna) — Principal investigator
First posted
Jun 1, 2022
Start date
May 25, 2022
Primary completion
Jun 30, 2022 (estimated)
Completion
Jul 31, 2022 (estimated)
Last update
Jun 7, 2022

Study contacts

Paolo Pillastrini
study director · Università degli studi di Bologna
Silvia Pozzan
principal investigator · Università degli studi di Bologna
Tommaso Torriglia
study chair · Università degli studi di Bologna

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion